semaglutide and optic neuritis Wegovy may raise risk of ischemic neuropathy ๐๏ธ The obesity drug semaglutide, marketed as Wegovy, was associated with a significantly higher risk of ischemic optic neuropathy than the diabetes formulation Ozempic Small NAION Risk from GLP-1
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Oct 22 - Oct 27



























:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)